These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19342647)

  • 1. Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis.
    Jendholm J; Mörgelin M; Perez Vidakovics ML; Carlsson M; Leffler H; Cardell LO; Riesbeck K
    J Immunol; 2009 Apr; 182(8):4713-20. PubMed ID: 19342647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production.
    Jendholm J; Samuelsson M; Cardell LO; Forsgren A; Riesbeck K
    J Leukoc Biol; 2008 Jun; 83(6):1370-8. PubMed ID: 18372337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.
    Hadzic R; Forsgren A; Cardell LO; Riesbeck K; Wingren AG
    Scand J Immunol; 2005 Feb; 61(2):165-72. PubMed ID: 15683453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.
    Nordström T; Jendholm J; Samuelsson M; Forsgren A; Riesbeck K
    J Leukoc Biol; 2006 Feb; 79(2):319-29. PubMed ID: 16301327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell activation by outer membrane vesicles--a novel virulence mechanism.
    Vidakovics ML; Jendholm J; Mörgelin M; Månsson A; Larsson C; Cardell LO; Riesbeck K
    PLoS Pathog; 2010 Jan; 6(1):e1000724. PubMed ID: 20090836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for TLRs in Moraxella-superantigen induced polyclonal B cell activation.
    Singh K; Bayrak B; Riesbeck K
    Front Biosci (Schol Ed); 2012 Jan; 4(3):1031-43. PubMed ID: 22202107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activation of naive T cells by antigen-presenting B cells.
    Morris SC; Lees A; Finkelman FD
    J Immunol; 1994 Apr; 152(8):3777-85. PubMed ID: 8144947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
    Ruprecht CR; Lanzavecchia A
    Eur J Immunol; 2006 Apr; 36(4):810-6. PubMed ID: 16541472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
    Petterson T; Jendholm J; Månsson A; Bjartell A; Riesbeck K; Cardell LO
    J Leukoc Biol; 2011 Feb; 89(2):177-87. PubMed ID: 20844241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of surface immunoglobulin in B lymphocyte activation.
    Finkelman FD; Vitetta ES
    Fed Proc; 1984 Aug; 43(11):2624-32. PubMed ID: 6611276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release.
    Hadzic R; Nita I; Tassidis H; Riesbeck K; Wingren AG; Janciauskiene S
    Immunol Lett; 2006 Feb; 102(2):141-7. PubMed ID: 16214222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for the development of human IgD-only B cells: Genotypic analyses suggest their generation in superantigen driven immune responses.
    Seifert M; Steimle-Grauer SA; Goossens T; Hansmann ML; Bräuninger A; Küppers R
    Mol Immunol; 2009 Feb; 46(4):630-9. PubMed ID: 18952293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors in tonsillar epithelial cells.
    Lange MJ; Lasiter JC; Misfeldt ML
    Int J Pediatr Otorhinolaryngol; 2009 Apr; 73(4):613-21. PubMed ID: 19167100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
    Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
    J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of adjuvants on B cells.
    Vollmer J; Bellert H
    Methods Mol Biol; 2010; 626():131-48. PubMed ID: 20099126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens.
    Forsgren A; Penta A; Schlossman SF; Tedder TF
    Cell Immunol; 1988 Mar; 112(1):78-88. PubMed ID: 2449982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
    Jiang W; Lederman MM; Harding CV; Rodriguez B; Mohner RJ; Sieg SF
    Eur J Immunol; 2007 Aug; 37(8):2205-13. PubMed ID: 17621369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
    J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.
    Manjarrez-Orduño N; Moreno-García ME; Fink K; Santos-Argumedo L
    Eur J Immunol; 2007 Feb; 37(2):358-67. PubMed ID: 17274001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.